Align Technology's Valuation Adjusted Amidst Flat Financial Performance and Limited Growth Prospects

Align Technology, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. The company's valuation grade has been revised from attractive to fair, reflecting a shift in its financial metrics.
Currently, Align Technology's P/E ratio stands at 29, while its Price to Book Value is noted at 3.45. The EV to EBIT ratio is recorded at 18.76, and the EV to EBITDA ratio is at 15.24. Additionally, the EV to Sales ratio is 3.08, and the PEG ratio is reported at 5.85. The company has demonstrated a return on capital employed (ROCE) of 22.11% and a return on equity (ROE) of 11.95%, indicating a level of management efficiency.

Despite these metrics, Align Technology has experienced flat financial performance in the quarter ending June 2025. The company has also shown a low debt to equity ratio, which is favorable. However, its long-term growth appears limited, with an operating profit growth rate of 18.90% over the past five years. The stock has generated a return of -44.23% over the past year, underperforming against the S&P 500 in various time frames.

For further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.